drug

COYA-302

1 story · latest Aug 11, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Coya Therapeutics

Timeline

Coya Therapeutics reports Q2 2026 results, updates ALSTARS trial and FTD plans

Aug 11Quarterly updateCoya Therapeutics

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.